Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Transarterial (chemo)embolisation Versus No Intervention or Placebo for Liver Metastases." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431401/all/Transarterial__chemo_embolisation_versus_no_intervention_or_placebo_for_liver_metastases.
Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431401/all/Transarterial__chemo_embolisation_versus_no_intervention_or_placebo_for_liver_metastases. Accessed December 8, 2024.
Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431401/all/Transarterial__chemo_embolisation_versus_no_intervention_or_placebo_for_liver_metastases
Transarterial (chemo)embolisation Versus No Intervention or Placebo for Liver Metastases [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431401/all/Transarterial__chemo_embolisation_versus_no_intervention_or_placebo_for_liver_metastases.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases
ID - 431401
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431401/all/Transarterial__chemo_embolisation_versus_no_intervention_or_placebo_for_liver_metastases
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -